{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:56Z","timestamp":1791229496673,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10072-023-07187-9","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:05:02Z","timestamp":1700474702000},"page":"2191-2197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder\u2013related optic neuritis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2198-0330","authenticated-orcid":false,"given":"Qinglin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"7187_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805\u2013815","journal-title":"Lancet Neurol"},{"key":"7187_CR2","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1212\/NXI.0000000000000607","volume":"6","author":"M Sepulveda","year":"2019","unstructured":"Sepulveda M, Delgado-Garc\u00eda G, Blanco Y et al (2019) Late-onset neuromyelitis optica spectrum disorder: the importance of autoantibody serostatus. Neurol Neuroimmunol Neuroinflamm 6:e607","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7187_CR3","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1111\/ene.14901","volume":"28","author":"K Nakahara","year":"2021","unstructured":"Nakahara K, Nakane S, Nagaishi A et al (2021) Very late onset neuromyelitis optica spectrum disorders. Eur J Neurol 28:2574\u20132581","journal-title":"Eur J Neurol"},{"key":"7187_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s00415-020-09699-2","volume":"267","author":"E Carnero Contentti","year":"2020","unstructured":"Carnero Contentti E, Daccach Marques V, Soto de Castillo I et al (2020) Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort. J Neurol 267:1260\u20131268","journal-title":"J Neurol"},{"key":"7187_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1532-5415.2011.03435.x","volume":"59","author":"R Lefaucheur","year":"2011","unstructured":"Lefaucheur R, Bourre B, Ahtoy P et al (2011) Neuromyelitis optica with very late onset. J Am Geriatr Soc 59:1138\u20131140","journal-title":"J Am Geriatr Soc"},{"key":"7187_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000505231","volume":"12","author":"S Fujiwara","year":"2020","unstructured":"Fujiwara S, Manabe Y, Morihara R et al (2020) Two cases of very-late-onset neuromyelitis optica spectrum disorder (NMOSD) in patients over the age of 80. Case Rep Neurol 12:13\u201317","journal-title":"Case Rep Neurol"},{"key":"7187_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00415-015-7766-8","volume":"262","author":"M Krumbholz","year":"2015","unstructured":"Krumbholz M, Hofstadt-van Oy U, Angstwurm K et al (2015) Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75. J Neurol 262:1379\u20131384","journal-title":"J Neurol"},{"key":"7187_CR8","doi-asserted-by":"publisher","first-page":"102515","DOI":"10.1016\/j.msard.2020.102515","volume":"46","author":"LJ Cai","year":"2020","unstructured":"Cai LJ, Zhang Q, Zhang Y et al (2020) Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 46:102515","journal-title":"Mult Scler Relat Disord"},{"key":"7187_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2147\/OPTH.S295769","volume":"15","author":"W Thongmee","year":"2021","unstructured":"Thongmee W, Narongkhananukul C, Padungkiatsagul T et al (2021) Comparison of early- and late-onset NMOSD-related optic neuritis in Thai patients: clinical characteristics and long-term visual outcomes. Clin Ophthalmol 15:419\u2013429","journal-title":"Clin Ophthalmol"},{"key":"7187_CR10","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"7187_CR11","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","volume":"3","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda M, Armangu\u00e9 T, Sola-Valls N et al (2016) Neuromyelitis \u00b4optica spectrum disorders. Comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 3:e225","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7187_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1191\/0961203303lu383ed","volume":"12","author":"M Ramos-Casals","year":"2003","unstructured":"Ramos-Casals M, Garc\u00eda-Carrasco M, Brito MP et al (2003) Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus 12:341\u2013355","journal-title":"Lupus"},{"key":"7187_CR13","doi-asserted-by":"publisher","first-page":"578151","DOI":"10.1016\/j.jneuroim.2023.578151","volume":"382","author":"R Wang","year":"2023","unstructured":"Wang R, Sun DR, Du Q et al (2023) Serum antinuclear antibodies associate with severe disease activity in neuromyelitis optica spectrum disorder. J Neuroimmunol 382:578151","journal-title":"J Neuroimmunol"},{"key":"7187_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/ene.12714","volume":"23","author":"H Masuda","year":"2016","unstructured":"Masuda H, Mori M, Uzawa A et al (2016) Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Eur J Neurol 23:276\u2013281","journal-title":"Eur J Neurol"},{"key":"7187_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0961203311427550","volume":"21","author":"M Szmyrka-Kaczmarek","year":"2012","unstructured":"Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B et al (2012) Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus 21:412\u2013420","journal-title":"Lupus"},{"key":"7187_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"issue":"21","key":"7187_CR17","first-page":"00200","volume":"27","author":"A Petzold","year":"2022","unstructured":"Petzold A, Fraser CL, Abegg M et al (2022) Diagnosis and classification of optic neuritis. Lancet Neurol 27(21):00200\u201300209","journal-title":"Lancet Neurol"},{"key":"7187_CR18","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC et al (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"7187_CR19","doi-asserted-by":"publisher","first-page":"859276","DOI":"10.3389\/fneur.2022.859276","volume":"13","author":"J Yu","year":"2022","unstructured":"Yu J, Yan S, Niu P et al (2022) Relatively early and late-onset neuromyelitis optica spectrum disorder in central China: clinical characteristics and prognostic features. Front Neurol 13:859276","journal-title":"Front Neurol"},{"key":"7187_CR20","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1177\/1352458516685416","volume":"23","author":"JM Seok","year":"2017","unstructured":"Seok JM, Cho HJ, Ahn SW et al (2017) Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: a multicenter retrospective study in Korea. Mult Scler 23:1748\u20131756","journal-title":"Mult Scler"},{"key":"7187_CR21","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","volume":"91","author":"SH Kim","year":"2018","unstructured":"Kim SH, Mealy MA, Levy M et al (2018) Racial differences in neuromyelitis optica spectrum disorder. Neurology 91:e2089\u2013e2099","journal-title":"Neurology"},{"key":"7187_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1177\/1352458518786058","volume":"25","author":"Q Yang","year":"2019","unstructured":"Yang Q, Sun L, Wang Q et al (2019) Primary optic neuropathy in Beh\u00e7et\u2019s syndrome. Mult Scler 25:1132\u20131140","journal-title":"Mult Scler"},{"key":"7187_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.msard.2018.12.011","volume":"28","author":"MA Mealy","year":"2019","unstructured":"Mealy MA, Mossburg SE, Kim SH et al (2019) Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis\/preventive treatment, MRI lesion length and presence of symptomatic brain lesions. Mult Scler Relat Disord 28:64\u201368","journal-title":"Mult Scler Relat Disord"},{"key":"7187_CR24","doi-asserted-by":"publisher","first-page":"577051","DOI":"10.1016\/j.jneuroim.2019.577051","volume":"337","author":"M Margoni","year":"2019","unstructured":"Margoni M, Carotenuto A (2019) Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: a puzzle of autoimmunity. J Neuroimmunol 337:577051","journal-title":"J Neuroimmunol"},{"key":"7187_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12883-015-0417-y","volume":"15","author":"Z Mao","year":"2015","unstructured":"Mao Z, Yin J, Zhong X et al (2015) Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population. BMC Neurol 15:160","journal-title":"BMC Neurol"},{"key":"7187_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.11.012","volume":"328","author":"EJ Lee","year":"2019","unstructured":"Lee EJ, Lim YM, Kim SY et al (2019) The clinical and prognostic value of antinuclear antibodies in NMO-IgG seropositive neuromyelitis optica spectrum disorder. J Neuroimmunol 328:1\u20134","journal-title":"J Neuroimmunol"},{"key":"7187_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jns.2005.03.014","volume":"233","author":"M Schwartz","year":"2005","unstructured":"Schwartz M, Kipnis J (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci 233:163\u2013166","journal-title":"J Neurol Sci"},{"key":"7187_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/antib10010009","volume":"10","author":"IA Pashnina","year":"2021","unstructured":"Pashnina IA, Krivolapova IM, Fedotkina TV et al (2021) Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease. Antibodies (Basel) 10:9","journal-title":"Antibodies (Basel)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07187-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07187-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07187-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:34:33Z","timestamp":1713242073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07187-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["7187"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07187-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}